2
Registered trials
2
Recruiting
2
Unique sponsors
2
Unique IMPs
1
Commercial trials
Drug classes (ATC)
—
ATC code not specified
1
L
Oncology (ATC L)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
1 substance
Monoclonal antibody (human)
1 substance
Phase II:
2
Phase II
2 trials-
RecruitingSanofi-Aventis Recherche & Developpement CommercialRILIPRUBART
-
RecruitingAcademisch Ziekenhuis Leiden AcademicBELIMUMAB
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Sanofi-Aventis Recherche & Developpement | Commercial | 1 | Phase II | 1 |
| Academisch Ziekenhuis Leiden | Academic | 1 | Phase II | 1 |
New trials by year
2022
1
2026
1